FDA approves new Alzheimer’s drug that appears to slow progression of disease

Brasil Notícia Notícia

FDA approves new Alzheimer’s drug that appears to slow progression of disease
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 62 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 86%

BREAKING: FDA approves Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.

The FDA did not seek the advice of its advisory committee — which it did do before it controversially approved another Alzheimer’s drug developed by Biogen, called Aduhelm, in 2021.

Leqembi is not a cure; it aims to slow the progression of the disease by removing clumps of beta-amyloid —The benefit is small, experts say, but added anything that might give patients additional time with family and other loved ones is valuable.. The Centers for Medicare & Medicaid Services currently limits coverage of drugs that target amyloid in the brain, so uptake of the new medication may be limited at first, Ivan Cheung, the U.S. chairman and CEO of Eisai, told NBC News.

The Alzheimer's Association has said that based on the Eisai and Biogen phase 3 clinical trial results, the FDA should approve Leqembi for early-stage Alzheimer’s. The organization is urging the Centers for Medicare & Medicaid Services to revise its decision on new Alzheimer's treatments. Last year, in response to the poor data supporting Aduhelm's approval, the CMS said it wouldn’t cover Alzheimer’s drugs that target amyloid unless patients are in a clinical trial.

Making the drug more widely available could mean more patients have"many months more of recognizing their spouse, children and grandchildren," said Maria Carrillo, the chief science officer for the Alzheimer’s Association.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NBCNews /  🏆 10. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA Says Retail Pharmacies Can Now Offer Abortion PillsFDA Says Retail Pharmacies Can Now Offer Abortion PillsThe U.S. Food and Drug Administration finalized a regulatory change that allows retail pharmacies to offer abortion pills.
Consulte Mais informação »

A New FDA Rule Expands Access to Abortion Pills—Here's What We KnowA New FDA Rule Expands Access to Abortion Pills—Here's What We KnowSoon, abortion pills may be available at your local pharmacy.
Consulte Mais informação »

Sesame officially added to FDA's major food allergen listSesame officially added to FDA's major food allergen listA new federal law went into effect on Jan. 1 that requires all foods made and sold in the U.S. to be labeled if they contain sesame, which is now the nation's ninth major allergen.
Consulte Mais informação »

More retail pharmacies can now offer abortion pills after FDA rule changeMore retail pharmacies can now offer abortion pills after FDA rule changeThe Food and Drug Administration on Tuesday finalized a rule change that broadens...
Consulte Mais informação »

FDA Rules That Retail Pharmacies Can Offer Abortion MedicationFDA Rules That Retail Pharmacies Can Offer Abortion MedicationAbortion bans or restrictions will likely make it illegal to implement the new FDA rule in about half the states.
Consulte Mais informação »

The FDA Will Now Allow Abortion Pills to be Sold at Retail PharmaciesThe FDA Will Now Allow Abortion Pills to be Sold at Retail PharmaciesPreviously, the first in the two-pill cycle used in medication abortions—mifepristone—had to be accessed via specific doctors and/or mail-order pharmacies.
Consulte Mais informação »



Render Time: 2025-02-27 05:52:36